Dr. Brian Hawkins, Chief Technology Officer, Pluristyx, shares his thoughts on cell and gene therapy.
Pluristyx Featured in Labroots Webinar
Dr. Ben Fryer, Co-Founder and CEO of Pluristyx, presented to webinar participants the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and the manufacturing workflow, beginning with the starting cell source and MCB